Emergent BioSolutions Inc.EBSNYSE
Loading
EBITDA Margin Over TimeExpanding
Percentile Rank57
3Y CAGR+168.4%
5Y CAGR-6.8%
Year-over-Year Change
EBITDA as a percentage of revenue
3Y CAGR
+168.4%/yr
vs -48.4%/yr prior
5Y CAGR
-6.8%/yr
Recent acceleration
Acceleration
+216.8pp
Accelerating
Percentile
P57
Within normal range
vs 5Y Ago
0.7x
Contraction
Streak
2 yr
Consecutive growthExpanding
| Period | Value | YoY Change |
|---|---|---|
| TTM | 27.16% | +430.9% |
| 2024 | 5.12% | +214.2% |
| 2023 | -4.48% | -418.8% |
| 2022 | 1.40% | -95.1% |
| 2021 | 28.43% | -26.4% |
| 2020 | 38.62% | +65.0% |
| 2019 | 23.41% | +18.1% |
| 2018 | 19.82% | -36.4% |
| 2017 | 31.15% | +14.6% |
| 2016 | 27.19% | - |